Wei Zhang | Health Professions | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Wei Zhang | Health Professions | Best Researcher Award

Professor at School of Nursing, Jilin University, China

Dr. Zhang Wei is a distinguished professor at Jilin University’s School of Nursing, where she leads the Department of Obstetrics and Gynecology Nursing. Her extensive career encompasses significant contributions to maternal and child health nursing, mental health nursing, and nursing education. Dr. Zhang has published over 40 papers as the first or corresponding author, with more than 30 in SCI-indexed journals, underscoring her commitment to advancing nursing science.

Professional Profile

Education

Dr. Zhang’s academic journey began with a bachelor’s degree in Maternal and Child Health from Jilin University’s Norman Bethune College of Medicine in 2002. She then earned a master’s degree in Women’s Health from the same institution in 2005. Pursuing further specialization, she obtained her Ph.D. in Immunology from Jilin University’s First Hospital in 2012. Demonstrating a commitment to interdisciplinary research, Dr. Zhang completed a postdoctoral fellowship in Social Medicine and Health Management at Jilin University’s School of Public Health between 2015 and 2021.

Professional Experience

Dr. Zhang’s professional trajectory at Jilin University is marked by progressive academic appointments. She began as a teaching assistant in the School of Nursing in 2005, advanced to lecturer in 2008, and was promoted to associate professor in 2014. In September 2023, she achieved the rank of professor. Throughout her tenure, Dr. Zhang has been instrumental in curriculum development and has served on both the Academic and Teaching Committees of the School of Nursing.

Research Interests

Dr. Zhang’s research interests are diverse and impactful. She focuses on maternal and child health nursing, emphasizing health promotion and care for women during critical life stages such as pregnancy, perimenopause, and adolescence. Her work in mental health nursing addresses psychological well-being, while her studies in chronic disease management concentrate on nursing care and preventive measures for female reproductive system cancers, including breast and gynecological tumors. Additionally, Dr. Zhang is dedicated to nursing education, exploring innovative teaching models and methods, particularly in blended learning environments.

Research Skills

Dr. Zhang possesses a robust set of research skills, including proficiency in systematic reviews and meta-analyses, as evidenced by her publications on topics like the effectiveness of family-centered interventions for caregivers and internet-based cognitive behavioral therapy for cancer patients. She is adept at both qualitative and quantitative research methodologies, enabling her to conduct comprehensive studies that inform evidence-based nursing practices.

Awards and Honors

Throughout her career, Dr. Zhang has received numerous accolades recognizing her contributions to nursing education and research. Notably, she was awarded the third prize in the 17th Jilin Province Higher Education Scientific Research Achievement Awards in November 2022 for her work on blended teaching models in obstetrics and gynecology nursing. She also received the Excellence Award for Undergraduate “Classroom Teaching Quality” at Jilin University for the 2021-2022 academic year, reflecting her dedication to teaching excellence.

Conclusion

Dr. Zhang Wei’s exemplary career in nursing is characterized by her unwavering commitment to advancing healthcare through research, education, and leadership. Her multidisciplinary expertise and dedication to improving women’s health have significantly impacted both the academic community and clinical practice. Dr. Zhang continues to inspire future generations of nurses and healthcare professionals through her innovative work and steadfast dedication to the field.

Publication Top Notes

  1. “Effectiveness of Meaning-Centered Interventions on Existential Distress and Mental Health Outcomes in Cancer Survivors and Their Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Dongsheng Xu, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2025
    • Journal: Worldviews on Evidence-Based Nursing
  2. “Effects of Nurse-Led e-Health Interventions on the Health-Related Outcomes of Pregnant Women: A Systematic Review”
    • Authors: Yujie Han, Qi Tian, Mengmeng Xu, Ziqi Wang, Wei Zhang
    • Year: 2025
    • Journal: Journal of Clinical Nursing
  3. “The Impact of Simulation-Based Learning on Nursing Decision-Making Ability: A Meta-Analysis”
    • Authors: Wei Zhao, Mengmeng Xu, Qi Tian, Ziqi Wang, Wei Zhang
    • Year: 2024
    • Journal: Clinical Simulation in Nursing
  4. “Effectiveness of Family-Centered Interventions for Family Caregivers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
    • Authors: Ziqi Wang, Shuanghan Yu, Yantong Liu, Yujie Han, Wei Zhao, Wei Zhang
    • Year: 2024
    • Journal: Journal of Clinical Nursing
    • Citations: 2

 

Dirk Keiner | Health Professions | Innovation Excellence Award

Posted on by ScienceFather

Dr. Dirk Keiner | Health Professions | Innovation Excellence Award

Pharmacist at Sophien and Hufeland Clinic Weimar, Germany

Dirk Richard Keiner is an accomplished clinical pharmacist with significant contributions to the advancement of medication safety and clinical pharmacy practice. He is the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar and holds leadership roles in several professional organizations, including the ADKA Thüringen and G³ – Arbeitsgemeinschaft für moderne Medizin e.V. Keiner has also been deeply involved in education, serving as a lecturer at various institutions such as the SRH University of Health and University of Jena. His innovative research focuses on improving drug therapy management, particularly in geriatrics, oncology, and medication safety. With a vast publication record, numerous awards, and a long-standing commitment to advancing clinical pharmacy, Keiner is a recognized leader in his field.

Professional Profile

Education:

Keiner completed his pharmaceutical studies at the Ernst-Moritz-Arndt University of Greifswald, where he graduated with a degree in Pharmacy in 1996. He conducted his diploma thesis on the analysis of valerian root essential oil. Keiner further pursued a doctorate at the Humboldt University Berlin, earning a Dr. rer. nat. with magna cum laude in 2006. His doctoral research compared various instruments used to measure the quality of life in osteoporosis patients. His strong educational foundation is complemented by various advanced professional qualifications, including specialization in Clinical Pharmacy.

Professional Experience:

Keiner’s career spans multiple leadership roles in both pharmacy practice and academia. He currently serves as the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar, a position he has held since 2017. Prior to this, he led the pharmacy at SRH Zentralklinikum Suhl and Waldkrankenhaus Eisenberg. His experience also includes extensive work in hospital and community pharmacies. Keiner has been actively involved in professional organizations, including serving as a board member of the ADKA Thüringen and as a delegate in the LAK Thüringen. His diverse professional background showcases his commitment to improving clinical pharmacy and patient care.

Research Interests:

Keiner’s research interests lie primarily in the area of medication safety, particularly in improving drug therapy management for older adults and cancer patients. He focuses on addressing gender-specific aspects of medication therapy and exploring the impact of drug-sun interactions. His work also extends to the development of tools for preventing medication errors and optimizing patient outcomes in clinical settings. Keiner’s research aims to bridge gaps in clinical pharmacy by tackling real-world challenges, such as the safe use of medications in vulnerable populations and the integration of new technologies into clinical practice.

Research Skills:

Keiner’s research skills are rooted in his extensive clinical pharmacy expertise, particularly in medication therapy management and safety. He is adept at conducting in-depth analyses of pharmaceutical interventions, particularly in geriatrics and oncology. Keiner employs various research methodologies, including qualitative and quantitative approaches, to assess the efficacy of drug therapy and the risks associated with certain medications. His ability to translate research findings into practical clinical applications is a hallmark of his work. Moreover, Keiner is skilled in evaluating and improving patient outcomes through the design and implementation of clinical studies that focus on medication errors and therapeutic optimization.

Awards and Honors:

Keiner’s exceptional contributions to clinical pharmacy have earned him numerous prestigious awards. Notable recognitions include the Sanofi-Synthelabo Prize for innovative work in clinical pharmacy, the Authors’ Prize from Krankenhauspharmazie, and the 1st place in the “Patient-Oriented Services” competition by the Dr. Hellmuth-Häussermann Foundation. In 2024, he received the ADKA Innovation Prize for his work on medication safety in the clinical setting. These accolades highlight his dedication to improving patient safety and advancing the field of clinical pharmacy. Keiner’s awards reflect his significant impact on both the scientific community and the practical application of pharmacy in healthcare settings.

Conclusion:

Dirk Richard Keiner’s career exemplifies innovation in clinical pharmacy, with a focus on improving medication safety and therapy management. His strong track record of leadership, research, and education, coupled with several prestigious awards, positions him as a deserving candidate for the Research for Innovation Excellence Award. While there are opportunities for expanding the global and interdisciplinary reach of his work, his contributions to the field of clinical pharmacy are significant, and his leadership in research and education make him a standout nominee.

Publication Top Notes

  1. AMTS Risk Profile Abiraterone | AMTS-Risk profile Abiraterone
    • Authors: Keiner, D.
    • Journal : M
    • Year: 2024
    • Volume: 47(3), pp. 106–114
  2. I’m Sorry, What? | Wie Bitte?
    • Authors: Keiner, D., Hoffmann, K.
    • Journal: Deutsche Apotheker Zeitung
    • Year: 2024
    • Volume: 2024(9)
  3. Probiotics & Co. – What Is Guaranteed? | Probiotics & Co. – What Is Guaranteed?
    • Authors : Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(12)
  4. AMTS Risk Profile Apixaban | AMTS Risk Profile Apixaban
    • Authors : Kei
    • Journal : M
    • Year: 2023
    • Volume: 46(9), pp. 319–326
  5. Check-Change-Control: Management Aspects of Arterial Hypertension in Geriatric Patients | Management Aspects of Arterial Hypertension in Geriatric Patients
    • Authors: Keiner, D., Gockel, H.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(4), pp. 114–123
  6. Risk Pyramid Allopurinol | AMTS-Risk profile Allopurinol
    • Authors: Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(1), pp. 12–19
  7. Much Helps Much – Or Is It? | Much Helps Much – Or Is It Not?
    • Authors: Keiner, D., Picksak, G.
    • Journal : Kr
    • Year: 2022
    • Volume: 43(9), pp. 375–376
  8. Gender-Specific Aspects of Cancer Management – ​​Ready for the Future? | Gender-Specific Aspects in Oncology Care – Ready for the Future?
    • Authors : Ke
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 353–362
  9. Gender-Specific Aspects of Drug Therapy – The New Clinical Challenge? | Gender-Specific Aspects of Drug Therapy: The New Clinical Challenge?
    • Authors: Keiner, D.
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 363–366
  10. Gender-Sensitive Medication Management | Gender-Sensitive Medication Management
    • Authors : None,
    • Journal : M
    • Year: 2022
    • Volume: 45(8), pp. 312–314